Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up-Reference-Cited by-同舟云学术

Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up

Published:2017 Issue:8 Volume:7 Page:2314-2324
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

You Rui,Hua Yi-Jun,Liu You-Ping,Yang Qi,Zhang Yi-Nuan,Li Ji-Bin,Li Chao-Feng,Zou Xiong,Yu Tao,Cao Jing-Yu,Zhang Meng-Xia,Jiang Rou,Sun Rui,Mo Hao-Yuan,Guo Ling,Cao Ka-Jia,Lin Ai-Hua,Sun Ying,Qian Chao-Nan,Ma Jun,Chen Ming-Yuan

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis;Current Cancer Drug Targets;2024-09

2. Risk factor and prediction model development for severe radiation-induced oral mucositis in head and neck tumors;Future Oncology;2024-08-06

3. The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy;BMC Cancer;2024-08-02

4. Influence of COVID-19 Vaccination on Treatment-Related Adverse Events and Oncologic Outcomes of Non-metastatic Nasopharyngeal Carcinoma;2024-07-18

5. Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis;Frontiers in Oncology;2024-07-02